BSE to launch country’s first IPO by a stock exchange on Jan 23, looks to raise Rs 1,350 crore

NEW DELHI: India's second largest domestic stock exchange BSE on Friday said it would hit the market with its initial public offering (IPO) on January 23.

The IPO is expected to be sold in the price band of Rs 800-850 apiece, with existing investors offloading shares worth nearly Rs 1,350 crore through the offer.

BSE has 302 shareholders, including Singapore Exchange and a Citigroup unit, who will sell up to 15.4 million shares with a face value of Rs 2 each, the red herring prospectus filed with the market regulator Sebi said.

The issue will close on January 25.

The Singapore Stock Exchange (4.67 per cent), George Soros-promoted Quantum fund (3.68 lakh shares) and Atticus Mauritius (3.68 per cent) would be among the shareholders who would sell their entire holdings in the exchange.

Deutsche Borse, which holds 4.7 per cent stake in the stock exchange, is not among the selling shareholders. The Singapore Exchange and Deutsche Borse had acquired 5 per cent stake each in the exchange for a consideration of Rs 200.78 crore each in 2007.


Sebi had on January 3 given its nod to the IPO, nearly four months after BSE filed the papers with the market regulator on September 9. Sebi’s approval has come at a time when CDSL, a BSE arm (54.2 per cent held by the exchange), has filed papers with Sebi for an IPO.

NSE, BSE’s rival, filed papers with Sebi for its forthcoming Rs 10,000 crore IPO in December.

BSE shares will be listed on NSE.

Between FY2012 and FY16, average daily trading volume on BSE climbed to 407.5 million from 323.5 million. At the same time peer NSE saw its volume rise to 1,851.8 million from Rs 1,437.7 million.

Comments

Post a Comment

Popular posts from this blog

JCB India launches its new 3DX ecoXPERT

Image
JCB India launches its new 3DX ecoXPERT Designed to give significant savings in Fuel and Maintenance Integrated with “IntelliPerformance” India’s leading manufacturer of Earthmoving and Construction Equipment, JCB India launched its all new 3DX ecoXPERT Backhoe Loader in Bhopal.With JCB’s ‘IntelliPerformance’ technology, which efficiently manages the energy demands of the machine, the intelligent new 3DX ecoXPERT saves fuel and reduces maintenance costs, thus leading to significant savings.Mr. Subir Kumar Chowdhury, Managing Director & CEO of JCB India says, “We are delighted to have launched our new Backhoe Loader, the 3DX ecoXPERT. This new machine is designed to give up to 12% savings on fuel and up to 22% savings on maintenance. Equipped with ‘IntelliPerformance’ technology the machine comes with advanced telematics called JCB Livelink which enables real-time fleet management of equipment for our customers. JCB has pioneered in integrating Smart technologies such as Internet o
Read more

Dr. Reddy’s Laboratories announces the first generic launch , Delayed Release Tablets in the U.S. Market

Image
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the first-to-market launch of Naproxen and Esomeprazole Magnesium Delayed-Release Tablets, a therapeutic equivalent generic version of Vimovo ® (Naproxen and Esomeprazole Magnesium) Delayed-Release Tablets approved by the U.S. Food and Drug Administration (USFDA).“This launch is a testament to our core strengths in areas of research and development and intellectual property,” says Marc Kikuchi, Chief Executive Officer, North America Generics. “We are excited to be a part of forming the first generic market for Vimovo ®  Tablets and to provide an affordable treatment alternative for patients.” The Vimovo ® (Naproxen and Esomeprazole Magnesium) Delayed-Release Tablets brand had U.S. sales of approximately $414 million MAT for the most recent twelve months ending in December 2019 according to IQVIA Health*.Dr. Reddy’s Naproxen and Esome
Read more